Congress Materials – Congress of Clinical Rheumatology (CCR EAST 2025)
2025 Congress of Clinical Rheumatology | May 1-4 | Destin, FL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
A Novel Composite Endpoint Including Low Peripheral Joint Disease Activity State and Clear/Almost Clear Skin in Patients With Active Psoriatic Arthritis
Daniel Aletaha, Joseph F. Merola, Mohammed Sharaf, Natalie J. Shiff, Emmanouil Rampakakis, Kate Callaway, Francois Nantel, Frederic Lavie, Anna Molto, Alexis Ogdie
Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primary Sjögren’s Disease: Results From a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (DAHLIAS)
Jacques Eric Gottenberg, Kathy Sivils, Kim Campbell, Jada Idokogi, Kim Lo, Sophia G. Liva, Elizabeth Adamson, Harman Dhatt, Jonathan J. Hubbard, Ghaith Noaiseh
Efficacy and Safety of Subcutaneous Guselkumab Induction Therapy in Patients With Ulcerative Colitis: Results Through Week 12 From the Phase 3 ASTRO Study
Laurent Peyrin-Biroulet, Jessica R. Allegretti, Silvio Danese, Matthew Germinaro, Thomas Baker, Yelina Alvarez, Silke Jörgens, Lingjing Jiang, Hongyan Zhang, Stacey Fitch, Tadakazu Hisamatsu, David T. Rubin, Millie Long
Guselkumab for Treatment of Juvenile Psoriatic Arthritis: Data Extrapolation from Studies in Adjacent Adult and Pediatric Populations
Herta Crauwels,, Sarah Ringold, Samantha Howard, Bart Van Hartingsveldt, Valerie Smith, Meg Jett, Tristan Baguet, Elizabeth Adamson, Soumya D. Chakravarty, Jocelyn H. Leu
Longitudinal Evaluation of Neutrophil-to-Lymphocyte Ratio in Guselkumab-Treated Patients With Psoriatic Disease and Levels of Systemic Inflammation Associated With Elevated Cardiovascular Risk: Post Hoc Analysis
Joseph F. Merola, Alexis Ogdie, Arthur Kavanaugh, Evan Leibowitz, Emmanouil Rampakakis, Alejandro Lizano Corzo, Francois Nantel, Frederic Lavie, Katelyn Rowland, Enrique R. Soriano
On-Label Persistence Through 24 Months Among Patients With Psoriatic Arthritis Initiating Guselkumab or Subcutaneous TNF Inhibitors
Philip J. Mease, Jessica Walsh, Timothy P. Fitzgerald, Soumya D. Chakravarty, Bruno Emond, Carmine Rossi, Samuel Schwartzbein, Kana Yokoji, Yuxi Wang, Patrick Lefebvre, Dominic Pilon, Linda Hou, Lauren Hoffman-Arriaga, Shikha Singla, Joseph F. Merola
On-Label Persistence Through 24 Months in Patients With Psoriatic Arthritis Using Guselkumab or Subcutaneous Interleukin-17A Inhibitors
Philip J. Mease, Jessica Walsh, Timothy P. Fitzgerald, Soumya D. Chakravarty, Bruno Emond, Carmine Rossi, Samuel Schwartzbein, Kana Yokoji, Yuxi Wang, Patrick Lefebvre, Dominic Pilon, Linda Hou, Anthony Todd, Shikha Singla, Joseph F. Merola
Safety of Guselkumab in Inflammatory Bowel Disease Up to 1 Year: Integrated Safety Analysis of Phase 2 and 3 Studies in Crohn’s Disease and Ulcerative Colitis
Bruce E. Sands, Remo Panaccione, Silvio Danese, Julián Panés, Tadakazu Hisamatsu, Geert D’Haens, Rian Van Rampelbergh, Mobolaji Olurinde, Jacqueline Yee, Brittany Durgin, Thomas Baker, Shadi Yarandi, Matthew Germinaro, Marion L. Vetter, Hewei Li, Mauricio Rosas Ballina, Jessica R. Allegretti, Anita Afzali, David T. Rubin
VISIBLE: GUSELKUMAB IMPACT ON PSORIATIC ARTHRITIS THROUGH WEEK 48 IN PARTICIPANTS WITH MODERATE-TO-SEVERE PSORIASIS ACROSS ALL SKIN TONES
Alice B. Gottlieb, Amy McMichael, Tina Bhutani, Olivia Choi, Katelyn Rowland, Theodore Alkousakis, Jessica Vasquez, Tony Ma, Soumya D. Chakravarty, Daphne Chan, Stacey Fitch, Andrea Nguyen, Seemal R. Desai, Andrew Alexis, Joseph F. Merola
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.